It was reported that NV1042, an oncolytic HSV vector armed with IL-12, showed better efficacy than a GM-CSF armed vector of the same backbone (NV1034) in certain tumor-bearing mice models [25]. This evidence concerns the gene CSF2 and neoplasm.